A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid

BACKGROUND: Recent studies report a lower mortality rate during treatment with long-acting muscarinic antagonist (LAMA)/long-acting β(2)-agonist (LABA)/inhaled corticosteroid (ICS) versus LAMA/LABA in patients with symptomatic chronic obstructive pulmonary disease (COPD) and a history of exacerbatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Miravitlles, Marc, Verhamme, Katia, Calverley, Peter M A, Dreher, Michael, Bayer, Valentina, Gardev, Asparuh, de la Hoz, Alberto, Wedzicha, Jadwiga, Price, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924530/
https://www.ncbi.nlm.nih.gov/pubmed/35309285
http://dx.doi.org/10.2147/COPD.S350167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924530/
https://www.ncbi.nlm.nih.gov/pubmed/35309285
http://dx.doi.org/10.2147/COPD.S350167

Ejemplares similares